The UK’s Competition and Markets Authority has offered clearance to the proposed acquisition of AthroCare by Smith & Nephew, reports say, marking the final hurdle cleared in the parties’ efforts to finalize the deal.
The CMA concluded its Phase I investigation of the $1.7 billion medical technology merger. The companies had already secured approval from regulators in the US and Germany, according to reports.
Smith & Nephew’s acquisition aims to boost the company’s repair technology product portfolio, the company said, through AthroCare’s radio frequency expertise. The companies now expect to close the deal by May 29.
Stryker denies Smith & Nephew rumors
Clearance for Smith & Nephew’s acquisition came the same day US-based Stryker denied earlier reports that it plans to acquire Smith & Nephew’s orthopedic operations.
According to reports, the UK Takeover Panel requested an official statement from Stryker regarding the reports; the company cannot make a bid for Smith & Nephew for the next six months.
Full content: Health Point Capital and Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI